Physicians Realty Trust (NYSE:DOC) previous close was $18.22 while the outstanding shares total 210.53M. The firm has a beta of 0.78, a 12-month trailing P/E ratio of 56.00, and a growth ratio of 5.77. DOC’s shares traded lower over the last trading session, losing -0.11% on 06/04/21. The shares fell to a low of $18.08 before closing at $18.20. Intraday shares traded counted 2.14 million, which was -2.56% lower than its 30-day average trading volume of 2.09M. The stock’s Relative Strength Index (RSI) is 47.36, with weekly volatility at 1.41% and ATR at 0.31. The DOC stock’s 52-week price range has touched low of $16.42 and a $20.13 high.
Investors have identified the REIT – Healthcare Facilities company Physicians Realty Trust as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $3.93 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Physicians Realty Trust (DOC) Fundamentals that are to be considered.
DOC were able to record 34.03 million as free cash flow during the 08/12/2021 quarter of the year, this saw their quarterly net cash flow reduce by 1.43 million. In cash movements, the company had a total of 41.3 million as operating cash flow.
Potential earnings growth for Physicians Realty Trust (DOC)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/12/2021 quarter of the year, Physicians Realty Trust recorded a total of 113.34 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 5.22% coming in sequential stages and their sales for the 08/12/2021 quarter increasing by 1.67%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 81.38 million trying to sell their products during the last quarter, with the result yielding a gross income of 31.96 million. This allows shareholders to hold on to 210.53M with the recently reported earning now reading 0.08 cents per share. This is a figure that compared to analyst’s prediction for their 08/12/2021 (0.27 cents a share).
Having a look at the company’s valuation, the company is expected to record 1.13 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on DOC sounds very interesting.
Is the stock of DOC attractive?
In related news, Director, BLACK ALBERT JR bought 2,800 shares of the company’s stock in a transaction that recorded on Aug 28. The purchase was performed at an average price of 18.13, for a total value of 50,764. As the purchase deal closes, the SVP – Deputy CIO, Klein Daniel M now sold 4,208 shares of the company’s stock, valued at 75,912. Also, EVP – CFO, THEILER JEFFREY sold 27,200 shares of the company’s stock in a deal that was recorded on Aug 17. The shares were cost at an average price of 18.09 per share, with a total market value of 492,048. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.70%.
9 out of 17 analysts covering the stock have rated it a Buy, while 6 have maintained a Hold recommendation on Physicians Realty Trust. 0 analysts has assigned a Sell rating on the DOC stock. The 12-month mean consensus price target for the company’s shares has been set at $20.19.